BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1512 related articles for article (PubMed ID: 28404761)

  • 1. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCCN Guidelines Updates: New Immunotherapy Strategies for Improving Outcomes in Non-Small Cell Lung Cancer.
    Gubens MA; Davies M
    J Natl Compr Canc Netw; 2019 May; 17(5.5):574-578. PubMed ID: 31117034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; Dilling TJ; Dowell J; Gettinger S; Gubens MA; Hegde A; Hennon M; Lackner RP; Lanuti M; Leal TA; Lin J; Loo BW; Lovly CM; Martins RG; Massarelli E; Morgensztern D; Ng T; Otterson GA; Patel SP; Riely GJ; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Yanagawa J; Yang SC; Gregory KM; Hughes M
    J Natl Compr Canc Netw; 2021 Mar; 19(3):254-266. PubMed ID: 33668021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology.
    Riely GJ; Wood DE; Ettinger DS; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai AP; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Juloori A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Owen D; Owen DH; Patel SP; Patil T; Polanco PM; Riess J; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hang L
    J Natl Compr Canc Netw; 2024 May; 22(4):249-274. PubMed ID: 38754467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic non-small cell lung cancer: Where do we go next?
    Malik N; Palma D
    Lung Cancer; 2017 Apr; 106():145-147. PubMed ID: 28062090
    [No Abstract]   [Full Text] [Related]  

  • 7. Updates in Local-Regionally Advanced Non-Small Cell Lung Cancer.
    Tsao AS; Jolly S; Lee JM
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():553-562. PubMed ID: 31099691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-small cell lung cancer, version 1.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung cancer, version 2.2013.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Govindan R; Grannis FW; Grant SC; Horn L; Jahan TM; Komaki R; Kong FM; Kris MG; Krug LM; Lackner RP; Lennes IT; Loo BW; Martins R; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Shapiro TA; Swanson SJ; Tauer K; Wood DE; Yang SC; Gregory K; Hughes M;
    J Natl Compr Canc Netw; 2013 Jun; 11(6):645-53; quiz 653. PubMed ID: 23744864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.
    Santana-Davila R; Chow LQ
    Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
    [No Abstract]   [Full Text] [Related]  

  • 13. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
    Ettinger DS; Aisner DL; Wood DE; Akerley W; Bauman J; Chang JY; Chirieac LR; D'Amico TA; Dilling TJ; Dobelbower M; Govindan R; Gubens MA; Hennon M; Horn L; Lackner RP; Lanuti M; Leal TA; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel SP; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):807-821. PubMed ID: 30006423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light.
    Ackermann CJ; Reck M; Paz-Ares L; Barlesi F; Califano R
    Lung Cancer; 2019 Aug; 134():245-253. PubMed ID: 31319988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abandoning the Notion of Non-Small Cell Lung Cancer.
    Relli V; Trerotola M; Guerra E; Alberti S
    Trends Mol Med; 2019 Jul; 25(7):585-594. PubMed ID: 31155338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
    [No Abstract]   [Full Text] [Related]  

  • 17. New options on the horizon for nononcogene addicted non-small-cell lung cancer.
    Paglialunga L; Ricciardi S; D'Arcangelo M
    Future Oncol; 2018 Jun; 14(13s):19-28. PubMed ID: 29989449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.
    Pennell NA; Arcila ME; Gandara DR; West H
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():531-542. PubMed ID: 31099633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates in non-small cell lung cancer.
    Walker S
    Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).
    Majem M; Juan O; Insa A; Reguart N; Trigo JM; Carcereny E; García-Campelo R; García Y; Guirado M; Provencio M
    Clin Transl Oncol; 2019 Jan; 21(1):3-17. PubMed ID: 30446985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.